fbpx

Year

2011
Download press release here: Acacia_Pharma_starts_Phase_II_clinical_trail_f.PDF
DBV demonstrates ability of VIASKIN® to administer allergen via intact skin by targeting dendrictic cells for safe treatment of allergic disease. News_J_Immunol.pdf
The U.S. Food and Drug Administration has granted 510(k) clearance for Asante Solutions' Pearl Insulin Pump. ASANTE_press_release_051711.pdf
Syntaxin enters manufacturing agreement with SynCo Bio Partners B.V. Progresses Acromegaly programme towards clinic. SynCo_Bio_Release_9_5_2011_(2).pdf
The Lundbeck Foundation, KIRKBI and the members of Falck's Executive Management Board become principal shareholders of Falck and Nordic Capital Fund V (Nordic Capital") sells all its shares in Falck."
Funds to be used to complete two Phase II programmes
In 2010 the Lundbeck Foundation obtained a profit of DKK 2.7 billion (? 362 million) which is the second best result since its establishment in 1954.
Three Hungarian neuroscientists awarded the ? 1 million BRAIN PRIZE 2011 for their brilliant analysis of brain circuits involved in memory
1 2 3

News

Professor wants to develop a radioactive precision missile to target brain cancer
21. February 2020
New test exposes dangerous moles
14. February 2020
Asthma is programmed early in life
7. February 2020

Lundbeckfonden

Lundbeckfonden Ventures

Lundbeckfonden Emerge